← 產業報告目錄
Lung Cancer Diagnostic and Screening Market, By Test Type (Biomarkers Test (EGFR Mutation Test, KRAS Mutation Test, ALK Test, HER2 Test, Others) Imaging Test (Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan, Chest X-Ray, Others), Biopsy), By Cancer Type (Non-small cell lung cancer, Small Cell Lung Cancer Neurosurgery), By End User (Hospital Associated Labs, Independent Diagnostic Laboratories, Cancer Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
出版商 Coherent Market Insights出版日期 2026-07-01頁數 258報告編號 CMR-797941727d
授權報價
| Single User Price | $4,500 USD |
| Site License Price | $7,000 USD |
| Enterprisewide Price (Global Site License) | $10,000 USD |
報告摘要
Lung cancer begins in the lungs and may spread to lymph nodes or other organs in the body, such as the brain. Cancer from other organs also may spread to the lungs. When cancer cells spread from one organ to another, they are called metastases. Lung cancers usually are grouped into two main types such as small cell and non-small cell. These types of lung cancer grow differently and are treated differently. According American Cancer Society non-small cell lung cancer is more common than small cell lung cancer. Different people have different symptoms for lung cancer. Some people have symptoms related to the lungs. Some people whose lung cancer has spread to other parts of the body (metastasized) have symptoms specific to that part of the body. Lung cancer symptoms may include coughing that gets worse or prolonged coughing, chest pain, shortness of breath, wheezing, coughing of blood, feeling very tired all the time, weight loss with no known cause.
According to the Centers for Disease Control and Prevention, lung cancer is the third most common cancer in the U.S. Most people in the U.S. die from lung cancer than any other type of cancer. For instance, According American Cancer Society, an estimated 154,050 Americans were expected to die from lung cancer in 2018, accounting for approximately 25% of all cancer deaths. Doctors may perform several tests to confirm lung cancer such as biomarker test, imaging test, and biopsy.
Market Dynamics
Regulatory approvals and launches of new screening test are expected to propel growth of the global lung cancer diagnostic and screening market during the forecast period. For instance, in August 2020, the U.S. Food and Drug Administration approved the liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).
However, high cost of lung cancer screening test is also expected to limit the market growth. For instance, according to the American Board of International medicine a CT scan costs US$ 300 and more. These test one need to take periodically.
Key features of the study
• This report provides in-depth analysis of the global lung cancer diagnostic and screening market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026-2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global lung cancer diagnostic and screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Abbott, Illumina, Inc, Thermo Fischer Scientific, QIAGEN, Quest Diagnostics Incorporated, NeoGenomics, NanoString, Myriad Genetics, Inc. F. Hoffmann-La Roche Ltd., Danaher, Agilent Technologies, Inc., AstraZeneca, Sanofi, and Janssen Pharmaceuticals, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global lung cancer diagnostic and screening market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for lung cancer diagnostic and screening market, research and consulting firms, new entrants, and financial analysts.
Market Segmentation
• By Test Type
o Biomarkers Test
EGFR Mutation Test
KRAS Mutation Test
ALK Test
HER2 Test
Others
o Imaging Test
Computed Tomography (CT) scan
Positron Emission Tomography (PET) scan
Chest X-Ray
Others
o Biopsy
• By Cancer Type
o Non-small cell lung cancer
o Small Cell Lung Cancer Neurosurgery
• By End User
o Hospital Associated Labs
o Independent Diagnostic Laboratories
o Cancer Research Institutes
o Others
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Competitive Landscape
o Abbott
o Amgen Inc.
o Illumina, Inc.
o Thermo Fisher Scientific Inc.
o Lepu Medical Technology (Beijing)Co.,Ltd.
o AstraZeneca
o Hoffmann-La Roche Ltd
o Laboratory Corporation of America Holdings.
o Agilent Technologies, Inc.
o QIAGEN
o Quest Diagnostics Incorporated.
o NeoGenomics Laboratories.
o Myriad Genetics, Inc.
o GRAIL, LLC.
o DELFI Diagnostics
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Test Type
Market Snippet, By Cancer Type
Market Snippet, By End User
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Recent Test Launches
o Epidemiology
o Merger, Acquisition, and Collaborations
o Regulatory Scenario
o Key Developments
o PEST Analysis
4. Global Lung Cancer Diagnostic and Screening Market, By Test Type, 2021–2033, (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Biomarkers Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
Segment Trends
o EGFR Mutation Test
o KRAS Mutation Test
o ALK Test
o HER2 Test
o Others
o Imaging Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
Segment Trends
o Computed Tomography (CT) scan
o Positron Emission Tomography (PET) scan
o Chest X-Ray
o Others
o Biopsy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
Segment Trends
5. Global Lung Cancer Diagnostic and Screening Market, By Cancer Type, 2021–2033, (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Non-small cell lung cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
Segment Trends
o Small Cell Lung Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
Segment Trends
6. Global Lung Cancer Diagnostic and Screening Market, By End User, 2021–2033, (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Hospital Associated Labs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
o Independent Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
o Cancer Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
7. Global Lung Cancer Diagnostic and Screening Market, By Region, 2021–2033, (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o North America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 –2033, (US$ Mn)
o U.S.
o Canada
o Europe
Introduction
Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 –2033, (US$ Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 –2033, (US$ Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 –2033, (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Middle East
Introduction
Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 –2033, (US$ Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast,Y-o-Y Growth and By Test Type, 2021 –2033, (US$ Mn)
Market Size and Forecast, Y-o-Y Growth and By Cancer Type, 2021 –2033, (US$ Mn)
Market Size and Forecast,Y-o-Y Growth and By End User, 2021–2033, (US$ Mn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 –2033, (US$ Mn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Company Profiles
Abbott
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
Amgen Inc.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
Illumina, Inc.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
Thermo Fisher Scientific Inc.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
Lepu Medical Technology(Beijing)Co.,Ltd.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
AstraZeneca
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
F. Hoffmann-La Roche Ltd
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
Laboratory Corporation of America Holdings.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
Agilent Technologies, Inc.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
QIAGEN
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
Quest Diagnostics Incorporated.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
NeoGenomics Laboratories.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
Myriad Genetics, Inc.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
GRAIL, LLC.
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
DELFI Diagnostics
o Company Overview
o Product Portfolio
o Key Highlights
o Financial Overview
o Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
圖表清單 List of Tables & Figures
NA
NA
提及公司
o Abbotto Amgen Inc.o IlluminaInc.o Thermo Fisher Scientific Inc.o Lepu Medical Technology (Beijing)Co.Ltd.o AstraZenecao Hoffmann-La Roche Ltdo Laboratory Corporation of America Holdings.o Agilent TechnologiesInc.o QIAGENo Quest Diagnostics Incorporated.o NeoGenomics Laboratories.o Myriad GeneticsInc.o GRAILLLC.o DELFI Diagnostics
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們